Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive N-Acetylcysteine for Spontaneous Bacterial Peritonitis in Liver Cirrhosis
NCT07803952Phase 2Recruiting
- Sponsor
- Tanta University
- Start
- Oct 2026
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in spontaneous bacterial peritonitis (SBP) comparing Placebo + SOC with NAC + SOC (2 arms). Primary endpoint: Percentage change in ascitic-fluid polymorphonuclear (PMN) count at 48 hours. Started Oct 2026; status: recruiting.
02
Drugs
acetylcysteine
03
Conditions
spontaneous bacterial peritonitis (SBP)
Beyond the preview
Go deeper on NCT07803952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07803952.